News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Josh J. Carlson, PhD, MPH

Articles by Josh J. Carlson, PhD, MPH

Diagnosis and Management of TRK Fusion Cancer

ByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MD

January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

ByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPh

January 11th 2022

Latest Updated Articles

Diagnosis and Management of TRK Fusion Cancer
January 11th 2022
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
January 11th 2022

Trending on AJMC

Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer

FDA Approves Pirtobrutinib for Untreated CLL/SLL Without 17p Deletion

Preparing Practices for the Next Era of Hepatitis B Care

Oral Targeted Anticancer Medication Use Following High-Deductible Health Plan Enrollment

VBC Risk Is Outpacing Provider Readiness, CMS Must Act